PharmEasy’s FY23 operating revenue up 16% to Rs 6,644 crore; net loss widens 30%

PharmEasy’s parent firm API Holdings cut down its advertising and promotional expenses to Rs 235 crore, less than half of what it incurred on this account in FY22, while staff costs also eased 12% to Rs 1,283 crore.